Fact based stock research
Givaudan (SWX:GIVN)

CH0010645932

Givaudan stock research in summary

givaudan.com


Givaudan shares are more expensive than other comparable stocks. They show below average growth, are riskily financed, and are poor value. We recommend evaluating whether the future of the company Givaudan is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Country Switzerland
Industry Specialty Chemicals
Index SPI, SMI
Size class X-Large

June 2, 2022. Stock data may be delayed. Login to get the most recent research.



Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Givaudan from June 2, 2022.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.